Holen Sie sich die Stockscreener-App
6.43
1.42%
0.09
Handel nachbörslich:
6.43
Schlusskurs vom Vortag:
$6.34
Offen:
$6.3872
24-Stunden-Volumen:
20,196
Relative Volume:
0.34
Marktkapitalisierung:
$107.54M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-14.88M
KGV:
-6.5612
EPS:
-0.98
Netto-Cashflow:
$-10.29M
1W Leistung:
+0.47%
1M Leistung:
+7.89%
6M Leistung:
-1.53%
1J Leistung:
+9.91%
1-Tages-Spanne:
$6.25
$6.50
1-Wochen-Bereich:
$5.7513
$6.50
52-Wochen-Spanne:
$4.65
$10.24
Coya Therapeutics Inc Stock (COYA) Company Profile
Firmenname
Coya Therapeutics Inc
Sektor
Branche
Telefon
650.739.3939
Adresse
12645 MEMORIAL DR., SUITE F1 #305, HOUSTON
Vergleichen Sie COYA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
COYA
Coya Therapeutics Inc
|
6.43 | 106.04M | 0 | -14.88M | -10.29M | -0.98 |
|
VRTX
Vertex Pharmaceuticals Inc
|
374.98 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
569.90 | 60.58B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
418.91 | 54.99B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
674.90 | 42.25B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
307.23 | 32.93B | 3.81B | -644.79M | -669.77M | -6.24 |
Coya Therapeutics Inc Stock (COYA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-09 | Eingeleitet | Lake Street | Buy |
| 2024-12-04 | Eingeleitet | D. Boral Capital | Buy |
Coya Therapeutics Inc Aktie (COYA) Neueste Nachrichten
Understanding Coya Therapeutics Inc.’s price movementBuy Candidate Summary Based on Fundamentals - Newser
What drives Coya Therapeutics Inc. stock priceLightning-fast capital gains - Jammu Links News
Does Coya Therapeutics Inc. stock perform well during market downturnsTrack top-performing stocks in real-time - Jammu Links News
How does Coya Therapeutics Inc. generate profit in a changing economyFree Trend-Following Techniques - Jammu Links News
Coya Therapeutics, Inc. (COYA) Surges 10.7%: Is This an Indication of Further Gains? - MSN
Is it the right time to buy Coya Therapeutics Inc. stockGet daily updates on top-performing stocks - Jammu Links News
How many analysts rate Coya Therapeutics Inc. as a “Buy”Explosive earnings growth - Jammu Links News
Sector ETF performance correlation with Coya Therapeutics Inc.Buy and Exit Strategy Based on Momentum - newser.com
How strong is Coya Therapeutics Inc. company’s balance sheetUnlock powerful portfolio optimization tools - Jammu Links News
What catalysts could drive Coya Therapeutics Inc. stock higher in 2025Overwhelming financial success - Jammu Links News
What institutional investors are buying Coya Therapeutics Inc. stockAchieve breakthrough results with expert guidance - Jammu Links News
Is Coya Therapeutics Inc. a growth stock or a value stockTremendous growth opportunities - Jammu Links News
What are the technical indicators suggesting about Coya Therapeutics Inc.Get insider insights into market trends - Jammu Links News
What are Coya Therapeutics Inc. company’s key revenue driversCapitalize on emerging trends for profits - Jammu Links News
Is Coya Therapeutics Inc. stock ready for a breakoutReal Market Tracker with Price Action Tools - Newser
Should you wait for a breakout in Coya Therapeutics Inc.Free Top Gaining Picks With Entry Signals - Newser
Using Python tools to backtest Coya Therapeutics Inc. strategiesMachine Learning Stock Price Forecast Tool - Newser
Why Coya Therapeutics Inc. stock attracts strong analyst attentionTrade Safety Matrix for Conservative Traders - Newser
Strategies to average down on Coya Therapeutics Inc.Chart Based Entry Tool for ROI Traders - Newser
How to manage a losing position in Coya Therapeutics Inc.Intraday Strategy with Real Time Monitoring - Newser
Applying Wyckoff theory to Coya Therapeutics Inc. stockFree AI Screening for Swing Trade Picks - Newser
Is Coya Therapeutics Inc. stock overvalued or undervaluedTop Growth Forecasts Backed By Experts - Jammu Links News
Price action breakdown for Coya Therapeutics Inc.Free Fundamental Winners With Safe Entry Plan - Newser
Published on: 2025-07-31 11:13:46 - metal.it
Published on: 2025-07-30 21:39:20 - Newser
Merck to discontinue drug from Pandion deal; Coya’s IND for ALS drug is delayed - Endpoints News
Buy Signal for Coya Therapeutics Inc. Stock Key Technical Indicators to WatchROI Focused Setup With Drawdown Analysis - Newser
Coya Therapeutics IncFDA unable to meet review goal date for Coya's IND for phase 2 ALS studySEC filing - MarketScreener
Coya Therapeutics, Inc. Announces Update on Investigational New Drug Application - MarketScreener
How Resilient Is Coya Therapeutics Inc. Stock During Economic DownturnsDaily Chart Pattern Stock Forecast Shows Bullish Setup - metal.it
What makes Coya Therapeutics Inc. stock price move sharplyFree Weekly Return Pick Forecast Reports - Newser
What is Coya Therapeutics Inc. company’s growth strategyStock Strategy Insights For Consistent Profits - Jammu Links News
Coya Therapeutics Inc. Stock Performance After Earnings: Historical Insights3-Year Equity Summary With Setup Insights - Newser
Why Coya Therapeutics Inc. stock attracts strong analyst attention Sector Rotation and Stock Opportunity Analysis - Newser
How volatile is Coya Therapeutics Inc. stock compared to the marketDiscover high-impact stocks for growth - Jammu Links News
How does Coya Therapeutics Inc. compare to its industry peersStrong return on assets - Jammu Links News
Finanzdaten der Coya Therapeutics Inc-Aktie (COYA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.40%
0.08%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):